Premium
P68: Dupilumab provides improvement in sleep in children aged ≥ 6 years with severe atopic dermatitis (AD) and adolescents with moderate‐to‐severe AD
Author(s) -
Jonathan A. Bernstein,
Marcus Maurer,
A Gim Enez-Arnau,
Weily Soong,
Gordon L. Sussman,
Martin Metz,
B Lanier,
Karl Sitz,
Michihiro Hide,
Eva Hua,
Avantika Barve,
Thomas Severin,
Reinhold Janocha
Publication year - 2021
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/bjd.20033
Subject(s) - dupilumab , atopic dermatitis , medicine , dermatology , pediatrics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom